Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictors of sensitivity and resistance to epidermal growth factor receptor inhibitors.

Clinical lung cancer - 1 Dec 2004

Perea Sofia, Hidalgo Manuel

Abstract excerpt

Lung cancer is one of the leading types of cancer with an associated high mortality. Currently, treatment with conventional cytotoxic agents remains suboptimal. Inhibition of the epidermal growth factor receptor (EGFR) with monoclonal antibodies or small-molecule inhibitors of the tyrosine kinase (TK) domain of the receptor have demonstrated modest, albeit significant, antitumor activities in patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Drug Resistance, Neoplasm
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Patient Selection

Share to Pharmacogenetics

Share to Pharmacokinetics

Share to Predictive Value of Tests

Share to Protein Kinase Inhibitors

Source

Identifiers

PMID: 15638955
DOI: 10.3816/clc.2004.s.012

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictors of sensitivity and resistance to epidermal growth factor receptor inhibitors.PMID 15638955Read ↗

Advances in EGFR as a Predictive Marker in Lung Adenocarcinoma.Semantic proximity Read ↗

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer.Semantic proximity Read ↗

Epidermal growth factor receptor mutations in non-small cell lung cancer: a basic science discovery with immediate clinical impact.Semantic proximity Read ↗

The importance of molecular profiling in predicting response to epidermal growth factor receptor family inhibitors in non-small-cell lung cancer: focus on clinical trial results.Semantic proximity Read ↗

Predictive factors for response and for resistance to tyrosine kinase inhibitor therapy in lung cancer.Semantic proximity Read ↗

The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC.Semantic proximity Read ↗

From clinical trials to clinical practice: predictors of response to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy.Semantic proximity Read ↗

Predictive biomarkers to tyrosine kinase inhibitors for the epidermal growth factor receptor in non-small-cell lung cancer.Semantic proximity Read ↗

Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis.Semantic proximity Read ↗

Pharmacodynamic biomarkers: falling short of the mark?Semantic proximity Read ↗

The applicability of a predictive index for second- and third-line treatment of unselected non-small-cell lung cancer patients.Semantic proximity Read ↗

Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.